Researchers recently conducted a meta-regression to examine how modifiable factors impact **HIV-related mortality in children** on antiretroviral therapy (ART). While ART significantly improves survival, disparities remain stark between resource-rich and resource-limited settings. Consequently, identifying country-level interventions beyond medication is vital for pediatric health.

Protecting Health with PCV3 and Water Access

The study analyzed 67 cohort studies involving children aged 0-14 years. It identified three primary modifiable factors that significantly lower the risk of **HIV-related mortality in children**. Specifically, access to improved water, PCV3 coverage, and maternal education showed the strongest associations with survival. Furthermore, the data suggests a 10% increase in water access correlates with a 17% reduction in mortality odds. Additionally, increasing PCV3 coverage and maternal education provided measurable protection. When these factors increased by 20%, the protective associations became even stronger.

Public Health Strategies Beyond Antiretroviral Therapy

These findings underscore the necessity of an integrated public health approach. While ART is essential, clinicians must also focus on structural improvements. For instance, strengthening water infrastructure and vaccination programs directly addresses leading causes of death. Moreover, supporting maternal education empowers caregivers to manage health effectively. In India, where pediatric HIV care faces challenges, these insights provide a roadmap for reducing survival disparities.

Frequently Asked Questions

What are the top three protective factors against HIV-related mortality in children?

The three most significant protective factors identified are access to improved water, third-dose pneumococcal conjugate vaccine (PCV3) coverage, and maternal education levels.

How does water access impact children on ART?

Improved water access reduces the risk of enteric infections and diarrhea, which are major contributors to mortality in children living with HIV, even those receiving ART.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

He J et al. Risk and Protective Factors Associated With HIV-Related Mortality in Children Receiving Antiretroviral Therapy: A Model-Based Meta-Regression. JAMA Pediatr. 2026 May 04. doi: 10.1001/jamapediatrics.2026.1235. PMID: 42081240.

Bansode V et al. Retrospective cohort analysis of survival of children living with HIV/AIDS in Mumbai, India. BMJ Open. 2021;11(11):e050395. doi: 10.1136/bmjopen-2021-050395.

Wolf J et al. Impact on childhood mortality of interventions to improve drinking water, sanitation, and hygiene (WASH) to households: Systematic review and meta-analysis. PLoS Med. 2018;15(8):e1002623. doi: 10.1371/journal.pmed.1002623.